BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122,950,916 | +43.5% | 4,662,530 | -6.4% | 7.17% | +49.5% |
Q2 2023 | $85,655,639 | +113258.1% | 4,979,979 | +9.3% | 4.80% | -3.6% |
Q1 2023 | $75,562 | +624.3% | 4,557,414 | +232.9% | 4.98% | +612.9% |
Q4 2022 | $10,433 | -99.9% | 1,369,179 | -6.8% | 0.70% | -31.6% |
Q3 2022 | $14,604,000 | +9.5% | 1,469,179 | 0.0% | 1.02% | +1.2% |
Q2 2022 | $13,340,000 | -16.2% | 1,469,179 | -6.4% | 1.01% | -17.5% |
Q1 2022 | $15,924,000 | -42.8% | 1,568,909 | -6.0% | 1.22% | -26.1% |
Q4 2021 | $27,837,000 | -66.4% | 1,668,909 | -5.7% | 1.66% | -50.8% |
Q3 2021 | $82,909,000 | -27.7% | 1,768,909 | -6.0% | 3.37% | -13.5% |
Q2 2021 | $114,665,000 | -14.2% | 1,880,980 | -13.3% | 3.90% | +30.9% |
Q1 2021 | $133,605,000 | -17.1% | 2,168,909 | -4.3% | 2.98% | -22.4% |
Q4 2020 | $161,118,000 | +89.5% | 2,265,762 | 0.0% | 3.83% | +17.3% |
Q3 2020 | $85,011,000 | +0.6% | 2,265,762 | -12.5% | 3.27% | +1.4% |
Q2 2020 | $84,485,000 | -1.2% | 2,590,762 | -12.2% | 3.22% | -18.9% |
Q1 2020 | $85,550,000 | -2.9% | 2,950,000 | +17.4% | 3.98% | +13.1% |
Q4 2019 | $88,076,000 | +56.7% | 2,512,865 | -4.0% | 3.52% | +2.7% |
Q3 2019 | $56,199,000 | -25.1% | 2,617,566 | -5.9% | 3.42% | -20.6% |
Q2 2019 | $75,000,000 | – | 2,780,885 | – | 4.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |